Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:55 PM
Ignite Modification Date:
2025-12-24 @ 3:55 PM
NCT ID:
NCT00267592
Eligibility Criteria:
Inclusion Criteria:
* Patients must be 18 years of age
* Patients must have histologically confirmed supratentorial Grade IV astrocytoma (glioblastoma multiforme)
* Patients must not have prior radiation therapy, chemotherapy (including Gliadel wafer), immunotherapy or therapy with a biologic agent, or hormonal therapy. Glucocorticoid therapy is allowed.
* Patients must have recovered from the immediate post-operative period and be maintained on a stable corticosteroid regimen (on increase for 5 days) prior to the start of treatment.
* Patients must have a Karnofsky performance of at least 60% or more.
Exclusion Criteria:
* Patients with serious concurrent infection or medical illness.
* Patients receiving concurrent chemotherapeutics or investigational agents.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00267592
Study Brief:
Protocol Section:
NCT00267592